China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)
上海旭东海普药业有限公司
Why it is here
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (上海省市场监管局上海市市场监督管理局 · 沪市监反垄处〔2023〕3220190101501号; 沪市监反垄处〔2023〕3220190101519号 · 市场监管总局发布上海旭东海普药业有限公司与天津天药医药科技有限公司达成并实施垄断协议案行政处罚决定书), from 2 June 2023.
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).
Details
- Company
- 上海旭东海普药业有限公司
- Authority
- State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
- Decision
- Cartel (monopoly agreement)
- Grounds and details, as published
- 上海省市场监管局上海市市场监督管理局 · 沪市监反垄处〔2023〕3220190101501号; 沪市监反垄处〔2023〕3220190101519号 · 市场监管总局发布上海旭东海普药业有限公司与天津天药医药科技有限公司达成并实施垄断协议案行政处罚决定书
- From
- 2 June 2023
- Until
- —
- Status
- End date not published
- Source
- https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_1a0affa78f854083b1f64d59ccf78e61.html
- Licence
- Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)
SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)